After Uzbekistan Health Ministry alleged Indian company Marion Biotech cough syrup responsible for the death of 18 children, a joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team.
The Central Drugs Standard Control Organisation (CDSCO) is in regular contact with the national drug regulator of Uzbekistan regarding the matter.
“Immediately on receipt of the information, joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team and further action as appropriate would be initiated based on the inspection report”, said union health ministry on Thursday.
The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing. Meanwhile, Marion Biotech Pharma company has said that it has sent samples of the said cough syrup for testing and has also halted the production of the product. Marion Biotech is a licensed manufacturer and holds license for manufacturing of Dok1 Max syrup and Tablet for export purpose granted by Drugs Controller, Uttar Pradesh.
Reacting to Navjot Singh Sidhu’s claim on wife’s cancer treatment and outcome, a group of oncologists…
The Union health ministry entered into a tripartite Memorandum of Understanding (MoU) with Banaras Hindu…
A recent claim by Punjabi leader and former cricketer Navjot Singh Sidhu regarding his wife…
Pancreatic cancer has been on a steady rise over the last 5-10 years can be…
Amid the worsening air pollution in Delhi and NCR region, the Indian Chest Society on…
Patients with heart disease, specifically those with heart failure, are especially vulnerable to the impacts…